Analyst Activity – Needham & Company LLC Reiterates Sell on ResMed (NYSE:RMD)

ME Staff
-
0

Analyst Ratings For ResMed (NYSE:RMD)

Today, Needham & Company LLC reiterated its Sell rating on ResMed (NYSE:RMD).

There are 4 sell ratings, 5 hold ratings, 2 buy ratings on the stock.

The current consensus rating on ResMed (NYSE:RMD) is Hold (Score: 1.82) with a consensus target price of $61.29 per share, a potential 20.90% downside.

Some recent analyst ratings include

  • 8/2/2017-Needham & Company LLC Reiterated Rating of Sell.
  • 8/2/2017-Citigroup Inc. Upgrade from a “Neutral ” rating to a ” Buy” rating.
  • 8/2/2017-Credit Suisse Group was Downgraded by analysts at Credit Suisse Group from a “Outperform ” rating to a ” Neutral” rating.
  • 8/2/2017-Bank of America Corporation was Downgraded by analysts at Bank of America Corporation from a “Buy ” rating to a ” Neutral” rating.
  • 5/12/2017-BMO Capital Markets Reiterated Rating of Hold.
  • 4/28/2017-Jefferies Group LLC Reiterated Rating of Sell.
  • 4/20/2017-J P Morgan Chase & Co was Downgraded by analysts at J P Morgan Chase & Co from a “Overweight ” rating to a ” Neutral” rating. They now have a $71.00 price target on the stock, up previously from $72.00 .

Dividend information for ResMed (NYSE:RMD)

ResMed (NYSE:RMD) pays an annual dividend of Community Ranking: with a yield of 1.70% and an average dividend growth of 14.50% based on a 3 Year Average.

Dividend History for ResMed (NYSE:RMD)

  • On 4/27/2017 ResMed announced a quarterly dividend of $0.33 1.94% with an ex dividend date of 5/9/2017 which will be payable on 6/15/2017.
  • On 1/23/2017 ResMed announced a quarterly dividend of $0.33 1.89% with an ex dividend date of 2/7/2017 which will be payable on 3/16/2017.
  • On 10/25/2016 ResMed announced a quarterly dividend of $0.33 2.18% with an ex dividend date of 11/8/2016 which will be payable on 12/15/2016.
  • On 7/28/2016 ResMed announced a quarterly dividend of $0.33 1.92% with an ex dividend date of 8/16/2016 which will be payable on 9/22/2016.
  • On 4/26/2016 ResMed announced a quarterly dividend of $0.30 2.12% with an ex dividend date of 5/17/2016 which will be payable on 6/16/2016.
  • On 1/21/2016 ResMed announced a quarterly dividend of $0.30 2.08% with an ex dividend date of 2/9/2016 which will be payable on 3/17/2016.
  • On 10/22/2015 ResMed announced a quarterly dividend of $0.30 2.13% with an ex dividend date of 11/17/2015 which will be payable on 12/17/2015.

Recent Insider Trading Activity For ResMed (NYSE:RMD)
ResMed (NYSE:RMD) has insider ownership of 1.97% and institutional ownership of 60.65%.

  • On 7/14/2017 James Hollingshead, Insider, sold 7,140 with an average share price of $77.43 per share and the total transaction amounting to $552,850.20. View SEC Filing
  • On 7/5/2017 Peter C Farrell, Director, sold 20,000 with an average share price of $76.50 per share and the total transaction amounting to $1,530,000.00. View SEC Filing
  • On 7/3/2017 Brett Sandercock, CFO, sold 1,250 with an average share price of $77.44 per share and the total transaction amounting to $96,800.00. View SEC Filing
  • On 7/3/2017 David Pendarvis, Insider, sold 6,364 with an average share price of $77.36 per share and the total transaction amounting to $492,319.04. View SEC Filing
  • On 6/29/2017 Jr. Gregor K Emmert, Insider, bought 282,000 with an average share price of $0.07 per share and the total transaction amounting to $19,740.00.
  • On 6/28/2017 Jr. Gregor K Emmert, Insider, bought 424,000 with an average share price of $0.06 per share and the total transaction amounting to $25,440.00.
  • On 6/22/2017 Richard Sulpizio, Director, sold 65,887 with an average share price of $77.82 per share and the total transaction amounting to $5,127,326.34. View SEC Filing

Recent Trading Activity for ResMed (NYSE:RMD)
Shares of ResMed closed the previous trading session at 73.59 down -3.89 -5.02% with 1,017,605 shares trading hands.